BIIB

BIIB

Biogen Inc
Biotechnology
$218.12 +0.62% As of Aug 24, 9:02 PM
Loading chart...
Interactive chart powered by TradingView

Trade Idea

Strategy
Live Scanner Strategy
Strikes
$220/215
Expiration
Sep 18
Target ROI
80.0%
Bullish Factors
High AI confidence rating, Moving averages show bullish trend
Risk Factors
Earnings announcement within 3 days

Technical Analysis

Squeeze Play: BIIB Preps for Breakout at $218.12

Neutral
Aug 24, 2026 at 9:02 PM • $218.12 (+0.62%)

The stock of Biogen Inc (BIIB) climbed 0.62% to close at $218.12 on August 24.

The technical setup looks bullish:

Moving Averages Moving averages are stacked bullishly—9-day EMA ($214.00) supports, 21-day ($210.24) below.
Momentum RSI at 59.9 is in neutral territory. MACD is bullish (3.57 vs signal 2.59).
Volatility A 20-day TTM Squeeze suggests volatility is coiled and a breakout may be imminent.
Key levels to watch: Support at $199.62, Resistance at $219.35.

BIIB Volatility Squeeze Intensifies at $216.78

Neutral
Aug 23, 2026 at 5:08 AM • $216.78 (+1.14%)

BIIB Range Contracts Sharply Near $216.78

Neutral
Aug 22, 2026 at 3:00 AM • $216.78 (+1.14%)

Calm Before Storm? BIIB Squeezes at $216.78

Neutral
Aug 21, 2026 at 9:01 PM • $216.78 (+1.14%)

BIIB Volatility Compresses at $214.35, Breakout Watch

Neutral
Aug 20, 2026 at 9:01 PM • $214.35 (-3.26%)
Systematic technical analysis • Updated daily after market close
Exclusive Offer

Get Trade Alerts

Receive disciplined options trade ideas with entries, targets & risk management.

Use code:
HEADSTART50
50% off your first month
Claim Offer Try Scanner

Key Stats

Entry Price $5.70
Max Profit $-10.70
Max Loss $5.70
Days to Exp 24
Trade Date Aug 24, 2026

Related Stocks

ABBV
ABBV
AbbVie Inc
AMGN
AMGN
Amgen Inc
MRNA
MRNA
Moderna Inc
REGN
REGN
Regeneron Pharmaceuticals Inc
VRTX
VRTX
Vertex Pharmaceuticals Inc
Disclaimer: This analysis is for educational purposes only. Options trading involves substantial risk. Past performance does not guarantee future results.